SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: Gene J. Abel who wrote (462)12/10/1997 10:46:00 AM
From: Chris Steele  Respond to of 2068
 
Gene, I feel that same as you do. And I was aware of the DLJ comment also.

Good luck all,

Chris



To: Gene J. Abel who wrote (462)12/10/1997 10:48:00 AM
From: Pierre Aydin  Respond to of 2068
 
I sold it yesterday and bought it today, I agree with u, We have Oxford Health Plan as health insurance and all the doctors that I and my brother go to don't have a problem collecting money.

Pierre



To: Gene J. Abel who wrote (462)12/10/1997 10:53:00 AM
From: Michael Burry  Read Replies (1) | Respond to of 2068
 
The key is not to say "they have no debt" because
LT debt is nil. If their reserves (read "accounts payable")
are indeed $1 billion, then that can be considered
debt due over the next 6 months that meets or exceeds their
liquid assets in AR and cash. This becomes a regulatory
issue, not purely an issue of business economics.

The stock may do very well, but I am stepping aside to
regain an unbiased view in light of this "disclosure" by
the WSJ, which may very well be a typo. My portfolio doesn't
depend on one stock, and I've found that when things get
too complicated, a timeout is worth the transaction costs.
In fact, I'd pin any succes I've had on it.

Good Investing,
Mike



To: Gene J. Abel who wrote (462)12/10/1997 11:23:00 AM
From: Thomas Haegin  Respond to of 2068
 
Re: All shoes dropped?

I personally am not going to *believe* any more good news or a turnaround until I actually see it in print before my own eyes.

By then the stock may be anywhere. If it's above my original entry by then, all the better. If it's lower, I will buy some more.

Thomas